The 2022 Misi Conference, hosted by Menet, was held in Huzhou on July 12, and the series of "Top 100 China Pharmaceutical Industry List 2021" were selected from two dimensions: innovation drive and professional promotion power. Among them, Sino Biopharm won the second place in the list of "Top 100 Chinese Chemical and Medical Enterprises in 2021".

The series of "Top 100 China Pharmaceutical Industry List 2021" are divided into 5 lists: "Top 100 Chinese Chemical and Medical Enterprises in 2021", "Top 100 China Traditional Chinese Medicine Enterprises", "Top 20 China CXO Enterprises", "Top 20 China Medical Devices (including IVD) Enterprises", and "Top 20 China Biopharmaceutical Enterprises (including blood products, vaccines, insulin, etc.)".

The total score of the selected companies is composed of two parts: the innovation driving force of the company, i.e. the R&D investment and R&D composite index score in 2021, accounting for 40% weighting; the second is the professional promotion force of the company, i.e. the terminal quantitative data determined by the final choice of clinicians and patients in 2021, accounting for 60% weighting.

See also:

“Top 100 Chinese Chemical and Medical Enterprises in 2021”
(Top 20)